Consulting & Advisory
Cell Therapies has been focused on enabling cellular therapies deployment in the Australasia region for over 15 years. With that experience comes a unique perspective on how best to translate a cellular therapy product from the lab to the patient, what considerations are necessary to get a product into the clinic, and when in the product lifecycle should reducing costs and validating assays be taken into account.
As each cellular therapy product is unique, the distinct regulatory, clinical, logistical, and manufacturing challenges that may arise will be varied and particular. We can perform a rapid diagnostic study to evaluate the target product and process design, resulting in recommendations that can help shape future process development strategies, manufacturing feasibility assessments, and the design of multi-centre / multi-country deployment models for commercial product.
CTPL’s consulting and advisory capability is a vital service offering that can assist organisations that need this expertise to advance their particular program through to commercial supply.